Default risk assessment procedures use threshold models for non-carcin
ogens and a non-threshold model for carcinogens. This a priori distinc
tion reflects the fact that the default procedures do not consider mec
hanisms of action of specific chemicals. When mechanisms are considere
d, the distinction is not necessary. Starting with the premise that th
e goal of risk assessment is to identify actual risk for specific chem
icals, three major, generic components of the overall mechanism transl
ating exposure into a response of regulatory interest are identified.
These are the specific mechanisms linking (1) exposure with dose to ta
rget tissue, (2) target tissue dose with short-term responses such as
cytolethality or mutation, and (3) short-term responses with ensuing l
ong-term responses such as cancer or cirrhosis. (Short-term responses
may be regulatory end points of interest, or they may be intermediate
steps on the way to longer-term sequelae). On-going research on formal
dehyde and chloroform is described to illustrate how these three compo
nents of the overall mechanism can be examined experimentally and used
in specific models. The impact of mechanism-based risk assessment on
uncertainty is also considered. Uncertainty is a function of the exten
t to which the model used for risk assessment misspecifies the actual
mechanism of action for the chemical in question. There is a trade-off
between (a) mechanism-based models that may reduce uncertainty but ar
e expensive and time-consuming to develop and (b) default models that
are not chemical-specific but can be used with minimal data sets. Expe
rience with mechanism-based risk assessment may allow modification of
default procedures to minimize this trade-off. A future default proced
ure for carcinogen risk assessment might allow specification of mode o
f action. For example, while DNA reactive-carcinogens would still be a
ssumed to have linear low-dose risk,carcinogens acting through purely
cytotoxic mechanisms might be assumed to have sharply non-linear or ev
en threshold dose-response curves.